Behavior of circulating endothelin-1 in a group of patients with acute myocardial infarction

Angiology

Volumn 50, Issue 8, 1999, Pages 629-638

  Battistelli, Sandra ^a   Billi, Mario ^b   Manasse, Giacomo ^b   Vittoria, Aurelio ^b   Roviello, Franco ^b   Forconi, Sandro ^b  

^a UNIVERSITY HOSPITAL OF SIENA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENDOTHELIN 1; GLYCERYL TRINITRATE; HEPARIN; LIDOCAINE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE NECROSIS; HOSPITAL ADMISSION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PROTEIN BLOOD LEVEL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032782022     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331979905000803     Document Type: Article

References (42)

1. Yanagisawa M, Kurihara H, Kimura S, et al: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411-415, 1988.
2. Myauchi T, Yanagisawa M, Tomisawa T, et al: Increased plasma concentration of endothelin-1 and big endothelin-1 in acute myocardial infarction [letter]. Lancet 2:53-54, 1989.
3. Salminen K, Tikkanen I, Saijonmaa O, et al: Modulation of coronary tone in acute myocardial infarction by endothelin [letter]. Lancet 2:747, 1989.
4. Yasuda M, Kohno M, Tahara A, et al: Circulating immunoreactive endothelin in ischemic heart disease. Am Heart J 119:801-806, 1990.
5. Stewart DJ, Kubac G, Costello KB, et al: Increased plasma endothelin-1 in the early hours of acute myocardial infarction. J Am Coll Cardiol 18:38-43, 1991.
6. Ray SG, McMurray JJ, Morton JJ, et al: Circulating endothelin in acute ischaemic syndromes. Br Heart J 67:383-386, 1992.
7. Lechleitner P, Genser N, Mair J, et al: Endothelin-1 in patients with complicated and uncomplicated myocardial infarction. Clin Invest 70:1070-1072, 1992.
8. Lechleitner P, Genser N, Mair J, et al: Plasma immunoreactive endothelin in the acute and subacute phases of myocardial infarction in patients undergoing fibrinolysis. Clin Chem 39:955-959, 1993.
9. Tomoda H: Plasma endothelin-1 in acute myocardial infarction with heart failure. Am Heart J 125:667-672, 1993.
10. Van Reet RE, Quinones MA, Poliner LR, et al: Comparison of two-dimensional echocardiography with gated radionuclide ventriculography in the evaluation of global and regional left ventricular function in acute myocardial infarction. J Am Coll Cardiol 3:243, 1984.
11. Emori T, Hirata Y, Ohta K, et al: Secretory mechanism of immunoreactive endothelin in cultured bovine endothelial cells. Biochem Biophys Res Commun 160:93-100, 1989.
12. Shini VB, Hendrickson H, Heublein DM, et al: Thrombin enhances the release of endothelin from cultured porcine aortic endothelial cells. Eur J Pharmacol 165:333-334, 1989.
13. Ragugi H, Tabuchi Y, Nakamaru M, et al: Evidence for endothelin-1 release from vessels of rats in response to hypoxia. Biochem Biophys Res Commun 169:973-977, 1990.
14. Velasco CE, Jackson EK, Morrow JA, et al: Intravenous adenosine suppresses cardiac release of endothelin after myocardial infarction ischaemia and reperfusion. Cardiovasc Res 27:121-128, 1993.
15. Watanabe T, Susuki N, Shimamoto N, et al: Contribution of endogenous endothelin to the extension of myocardial infarct size in rats. Circ Res 69:370-377, 1991.
16. Xu D, Emoto N, Giaid A, et al: ECE-1: A membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell 78:473-485, 1994.
17. Rossi GP, Albertin G, Franchin E, et al: Expression of the endothelin-converting enzyme gene in human tissues. Biochem Res Comm 2:249-258, 1995.
18. Margulies KB, Hildebrand FL Jr, Lerman A, et al: Increased endothelin in experimental heart failure. Circulation 82:222-230, 1990.
19. McMurray JJ, Ray SG, Abdullah I, et al: Plasma endothelin in chronic heart failure. Circulation 85:1374-1379, 1992.
20. Rodeheffer JE, Lerman A, Heublein DM, et al: Increased plasma concentrations of endothelin in congestive heart failure in humans. Mayo Clin Proc 67:719-724, 1992.
21. Lerman A, Heublein DM, Burnett JC Jr, et al: Congestive heart failure is characterized by systemic endothelin activation [abstract]. J Am Coll Cardiol 2:315A, 1993.
22. De Nucci G, Thomas R, D'Orleans-Juste P, et al: Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA 85:9797-9800, 1988.
23. Pernow J, Hemsn A, Lundbderg JM: Tissue specific distribution, clearance and vascular effects of endothelin in the pig. Biochem Biophys Res Commun 161:647-653, 1989.
24. Wagner OF, Vierhapper H, Gasic S, et al: Regional effects and clearance of endothelin-1 across pulmonary and splanchnic circulation. Eur J Clin Invest 22:277-282, 1992.
25. Anggard E, Galton S, Rae G, et al: The fate of radio-iodinated endothelin-1 and endothelin-3 in the rat. J Cardiovasc Pharmacol 13 (suppl 5):S46-49, 1989.
26. Sirvio ML, Metsarinne K, Saijonmaa O, et al: Tissue distribution and half-life of 1251-endothelin in the rat: Importance of pulmonary clearance. Biochem Biophys Res Commun 167:1191-1195, 1990.
27. Cernacek P, Stewart DJ: Immunoreactive endothelin in human plasma: Marked elevation in patients with cardiogenic shock. Biochem Biophys Res Commun 161:562-567, 1989.
28. Emori T, Hirata J, Ohta K, et al: Cellular mechanism of endothelin-1 release by angiotensin and vasopressin. Hypertension. 18:165-170, 1991.
29. Nunez DJR, Brown MJ, Davenport AP, et al: Endothelin-1 mRNA is widely expressed in porcine and human tissues. J Clin Invest 85:1537-1541, 1990.
30. Cody RJ, Haas GJ, Binkley PF, et al: Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure. Circulation 85:504-509, 1992.
31. Dupuis J, Stewart DJ, Cernacek P, et al: Human pulmonary circulation is an important site for both clearance and production of endothelin-1. Circulation 94:1578-1584, 1996.
32. Donckier JE, Hanet C, Berbinschi A, et al: Cardiovascular and endocrine effects of endothelin-1 at pathophysiological and pharmacological plasma concentrations in conscious dogs. Circulation 84:2476-2484, 1991.
33. Vierhapper H, Wagner O, Nowotny P, et al: Effect of endothelin in man. Circulation 81:1415-1418, 1990.
34. Lerman A, Hildebrand FL, Aarhus LL, et al: Endothelin has biological actions at pathophysiological concentrations. Circulation 83:1808-1814, 1991.
35. Stewart DJ, Baffour R: Functional state of the endothelium determines the response to endothelin in the coronary circulation. Cardiovasc Res 24:7-12, 1990.
36. Yorikane R, Shiga H, Miyake S, et al: Evidence for direct arrhythmogenic action of endothelin. Biochem Biophys Res Commun 173:457-462, 1990.
37. Salvati P, Chierchia S, Dho L, et al: Proarrhythmic activity of intracoronary endothelin in dogs: Relation to the site of administration and to changes in regional flow. J Cardiovasc Pharmacol 17:1007-1014, 1991.
38. Terashita Z, Shibouta Y, Imura Y, et al: Endothelin-induced sudden death and the possible involvement of platelets activating factor (PAF). Life Sci 45:1911-1918, 1989.
39. Muldoon LL, Pribnow D, Roland KD, et al: Endothelin-1 stimulates DNA synthesis and anchorage-independent growth of rat-1 fibroblasts through a protein kinase C-dependent mechanism. Cell Reg 1:379-390, 1990.
40. Komuro I, Kirihara H, Sugiyama T, et al: Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells. FEBS Lett 238:249-252, 1988.
41. Luscher TF: Endothelial control of vascular tone and growth. Clin Exp Hypertens (A) 12:897-902, 1990.
42. Bobik A, Grooms A, Millar JA, et al: Growth factor activity of endothelin on vascular smooth muscle. Am J Physiol 258:C408-415, 1990.